{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T09:41:25Z","timestamp":1780652485496,"version":"3.54.1"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2012\/24647-0"],"award-info":[{"award-number":["2012\/24647-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["402439\/2013-9"],"award-info":[{"award-number":["402439\/2013-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00705-016-3128-9","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T07:59:26Z","timestamp":1477900766000},"page":"323-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Rabies vaccine development by expression of recombinant viral glycoprotein"],"prefix":"10.1007","volume":"162","author":[{"given":"Renato Mancini","family":"Astray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraia Attie Calil","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Augusto","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"issue":"11","key":"3128_CR1","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1073\/pnas.83.11.3914","volume":"83","author":"N Tordo","year":"1986","unstructured":"Tordo N, Poch O, Ermine A, Keith G, Rougeon F (1986) Walking along the rabies genome: is the large G-L intergenic region a remnant gene? Proc Natl Acad Sci USA 83(11):3914\u20133918","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5784","key":"3128_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1126\/science.1127683","volume":"313","author":"S Roche","year":"2006","unstructured":"Roche S, Bressanelli S, Rey FA, Gaudin Y (2006) Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science 313(5784):187\u2013191","journal-title":"Science"},{"issue":"5","key":"3128_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1099\/0022-1317-80-5-1211","volume":"80","author":"PJ Walker","year":"1999","unstructured":"Walker PJ, Kongsuwan K (1999) Deduced structural model for animal rhabdovirus glycoproteins. J Gen Virol 80(5):1211\u20131220","journal-title":"J Gen Virol"},{"key":"3128_CR4","doi-asserted-by":"publisher","first-page":"1674580","DOI":"10.1155\/2016\/1674580","volume":"2016","author":"BG Fernando","year":"2016","unstructured":"Fernando BG, Yersin CT, Jos\u00e9 CB, Paola ZS (2016) Predicted 3D model of the rabies virus glycoprotein trimer. Biomed Res Int 2016:1674580. doi:10.1155\/2016\/1674580","journal-title":"Biomed Res Int"},{"issue":"1","key":"3128_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2217\/fvl.09.72","volume":"5","author":"X Sun","year":"2010","unstructured":"Sun X, Roth SL, Bialecki MA, Whittaker GR (2010) Internalization and fusion mechanism of vesicular stomatitis virus and related rhabdoviruses. Future Virol 5(1):85\u201396","journal-title":"Future Virol"},{"issue":"8","key":"3128_CR6","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/jvi.65.8.4198-4203.1991","volume":"65","author":"A Benmansour","year":"1991","unstructured":"Benmansour A, Leblois H, Coulon P, Tuffereau C, Gaudin Y, Flamand A, Lafay F (1991) Antigenicity of rabies virus glycoprotein. J Virol 65(8):4198\u201341203","journal-title":"J Virol"},{"issue":"23","key":"3128_CR7","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1016\/j.vaccine.2010.03.039","volume":"28","author":"N Johnson","year":"2010","unstructured":"Johnson N, Cunningham AF, Fooks AR (2010) The immune response to rabies virus infection and vaccination. Vaccine 28(23):3896\u20133901","journal-title":"Vaccine"},{"issue":"23","key":"3128_CR8","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1016\/j.vaccine.2011.03.096","volume":"29","author":"P Gautret","year":"2011","unstructured":"Gautret P, Tantawichien T, Vu Hai V, Piyaphanee W (2011) Determinants of pre-exposure rabies vaccination among foreign backpackers in Bangkok, Thailand. Vaccine 29(23):3931\u20133934","journal-title":"Vaccine"},{"issue":"3","key":"3128_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1586\/14760584.2015.973403","volume":"14","author":"M Kaur","year":"2015","unstructured":"Kaur M, Garg R, Singh S, Bhatnagar R (2015) Rabies vaccines: where do we stand, where are we heading? Expert Rev Vaccines. 14(3):369\u2013381","journal-title":"Expert Rev Vaccines."},{"issue":"9","key":"3128_CR10","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1371\/journal.pntd.0000515","volume":"3","author":"HCJ Ertl","year":"2009","unstructured":"Ertl HCJ (2009) Novel vaccines to human rabies. PLoS Negl Trop Dis 3(9):e515","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"3128_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5539\/gjhs.v8n3p113","volume":"8","author":"E Ortiz-Prado","year":"2015","unstructured":"Ortiz-Prado E, Ponce-Zea J, Ramirez D, Stewart-Ibarra AM, Armijos L, Yockteng J, Cardenas WB (2015) Rabies epidemiology and control in ecuador. Glob J Health Sci 8(3):113\u2013121","journal-title":"Glob J Health Sci"},{"issue":"25\u201326","key":"3128_CR12","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1016\/S0264-410X(02)00260-8","volume":"20","author":"V Yusibov","year":"2002","unstructured":"Yusibov V, Hooper DC, Spitsin SV, Fleysh N, Kean RB, Mikheeva T, Deka D, Karasev A, Cox S, Randall J, Koprowski H (2002) Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20(25\u201326):3155\u20133164","journal-title":"Vaccine"},{"issue":"52","key":"3128_CR13","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1016\/j.vaccine.2008.09.083","volume":"26","author":"ET Cruz","year":"2008","unstructured":"Cruz ET, Romero IAF, Mendoza JGL, Su\u00e1rez SO, Gonz\u00e1lez RH, Favela FB, Torres AP, Seti\u00e9n JAA (2008) Efficient post-exposure prophylaxis against rabies by applying a four-dose DNA vaccine intranasally. Vaccine 26(52):6936\u20136944","journal-title":"Vaccine"},{"issue":"3","key":"3128_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0264-410X(85)90224-5","volume":"3","author":"P Perrin","year":"1985","unstructured":"Perrin P, Thibodeau L, Sureau P (1985) Rabies immunosomes (sub-unit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies. Vaccine 3(3):325\u2013332","journal-title":"Vaccine"},{"issue":"5","key":"3128_CR15","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1128\/jvi.71.5.3742-3750.1997","volume":"71","author":"Y Gaudin","year":"1997","unstructured":"Gaudin Y (1997) Folding of rabies virus glycoprotein: Epitope acquisition and interaction with endoplasmic reticulum chaperones. J Virol 71(5):3742\u20133750","journal-title":"J Virol"},{"issue":"2","key":"3128_CR16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/jvi.23.2.286-293.1977","volume":"23","author":"B Dietzschold","year":"1977","unstructured":"Dietzschold B (1977) Oligosaccharides of the glycoprotein of rabies virus. J Virol 23(2):286\u2013293","journal-title":"J Virol"},{"issue":"4","key":"3128_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1099\/0022-1317-64-4-843","volume":"64","author":"M Lafon","year":"1983","unstructured":"Lafon M, Wiktor TJ, Macfarlan RI (1983) Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J Gen Virol 64(4):843\u2013851","journal-title":"J Gen Virol"},{"issue":"5","key":"3128_CR18","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.4049\/jimmunol.133.5.2748","volume":"133","author":"RI Macfarlan","year":"1984","unstructured":"Macfarlan RI, Dietzschold B, Wiktor TJ, Kiel M, Houghten R, Lerner RA, Sutcliffe JG, Koprowski H (1984) T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides. J Immunol 133(5):2748\u20132752","journal-title":"J Immunol"},{"issue":"6","key":"3128_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10875-006-9044-0","volume":"26","author":"SM Moore","year":"2006","unstructured":"Moore SM, Wilkerson MJ, Davis RD, Wyatt CR, Briggs DJ (2006) Detection of cellular immunity to rabies antigens in human vaccinees. J Clin Immunol 26(6):533\u2013545","journal-title":"J Clin Immunol"},{"issue":"2\u20134","key":"3128_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.vetmic.2012.11.031","volume":"162","author":"G Zhang","year":"2013","unstructured":"Zhang G, Wang H, Mahmood F, Fu ZF (2013) Rabies virus glycoprotein is an important determinant for the induction of innate immune responses and the pathogenic mechanisms. Vet Microbiol 162(2\u20134):601\u2013613","journal-title":"Vet Microbiol"},{"issue":"2","key":"3128_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0042-6822(92)90465-2","volume":"187","author":"Y Gaudin","year":"1992","unstructured":"Gaudin Y, Ruigrok RW, Tuffereau C, Knossow M, Flamand A (1992) Rabies virus glycoprotein is a trimer. Virology 187(2):627\u2013632","journal-title":"Virology"},{"issue":"Pt 9","key":"3128_CR22","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1099\/vir.0.81063-0","volume":"86","author":"L Sissoeff","year":"2005","unstructured":"Sissoeff L, Mousli M, England P, Tuffereau C (2005) Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor. J Gen Virol 86(Pt 9):2543\u20132552","journal-title":"J Gen Virol"},{"issue":"1","key":"3128_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1006\/viro.2002.1429","volume":"297","author":"S Roche","year":"2002","unstructured":"Roche S, Gaudin Y (2002) Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers. Virology 297(1):128\u2013135","journal-title":"Virology"},{"issue":"22","key":"3128_CR24","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","volume":"81","author":"TJ Wiktor","year":"1984","unstructured":"Wiktor TJ, Macfarlan RI, Reagan KJ, Dietzschold B (1984) Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci USA 81(22):7194\u20137198","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3128_CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","volume":"73","author":"C Jallet","year":"1999","unstructured":"Jallet C, Jacob Y, Bahloul C, Drings A, Desmezieres E, Tordo N, Perrin P (1999) Chimeric lyssavirus glycoproteins with increased immunological potential. J Virol 73(1):225\u2013233","journal-title":"J Virol"},{"issue":"25\u201326","key":"3128_CR26","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1016\/j.vaccine.2004.02.039","volume":"22","author":"DL Lodmell","year":"2004","unstructured":"Lodmell DL, Esposito JJ, Ewalt LC (2004) Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A\/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Vaccine 22(25\u201326):3329\u20133333","journal-title":"Vaccine"},{"issue":"36","key":"3128_CR27","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1016\/j.vaccine.2014.06.058","volume":"32","author":"P Koraka","year":"2014","unstructured":"Koraka P, Bosch BJ, Cox M, Chubet R, van Amerongena G, L\u00f6vgren-Bengtssone K, Martina BE, Roose J, Rottier PJ, Osterhaus AD (2014) A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice. Vaccine 32(36):4644\u20134650","journal-title":"Vaccine"},{"issue":"1","key":"3128_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/v4010117","volume":"4","author":"AVA Albertini","year":"2012","unstructured":"Albertini AVA, Baquero E, Ferlin A, Gaudin Y (2012) Molecular and cellular aspects of Rhabdovirus entry. Viruses 4(1):117\u2013139","journal-title":"Viruses"},{"issue":"1","key":"3128_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/13550280590900427","volume":"11","author":"M Lafon","year":"2005","unstructured":"Lafon M (2005) Rabies virus receptors. J Neurovirol 11(1):82\u201387","journal-title":"J Neurovirol"},{"issue":"2","key":"3128_CR30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/JVI.72.2.1085-1091.1998","volume":"72","author":"C Tuffereau","year":"1998","unstructured":"Tuffereau C, Benejean J, Alfonso AM, Flamand A, Fishman MC (1998) Neuronal cell surface molecules mediate specific binding to rabies virus glycoprotein expressed by a recombinant baculovirus on the surfaces of lepidopteran cells. J Virol 72(2):1085\u20131091","journal-title":"J Virol"},{"issue":"24","key":"3128_CR31","doi-asserted-by":"publisher","first-page":"13622","DOI":"10.1128\/JVI.02368-06","volume":"81","author":"C Tuffereau","year":"2007","unstructured":"Tuffereau C, Schmidt K, Langevin C, Lafay F, Dechant G, Koltzenburg M (2007) The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection. J Virol 81(24):13622\u201313630","journal-title":"J Virol"},{"issue":"24","key":"3128_CR32","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1093\/emboj\/17.24.7250","volume":"17","author":"C Tuffereau","year":"1998","unstructured":"Tuffereau C, B\u00e9n\u00e9jean J, Blondel D, Kieffer B, Flamand A (1998) Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J 17(24):7250\u20137259","journal-title":"EMBO J"},{"issue":"5","key":"3128_CR33","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<720::AID-MUS9>3.0.CO;2-5","volume":"23","author":"P Lewis","year":"2000","unstructured":"Lewis P, Fu Y, Lentz TL (2000) Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures. Muscle Nerve 23(5):720\u2013730","journal-title":"Muscle Nerve"},{"issue":"9","key":"3128_CR34","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1128\/JVI.72.9.7181-7190.1998","volume":"72","author":"MI Thoulouze","year":"1998","unstructured":"Thoulouze MI, Lafage M, Schachner M, Hartmann U, Cremer H, Lafon M (1998) The neural cell adhesion molecule is a receptor for rabies virus. J Virol 72(9):7181\u20137190","journal-title":"J Virol"},{"issue":"2","key":"3128_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0042-6822(91)90539-N","volume":"185","author":"MA Whitt","year":"1991","unstructured":"Whitt MA, Buonocore L, Prehaud C, Rose JK (1991) Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein. Virology 185(2):681\u2013688","journal-title":"Virology"},{"issue":"3","key":"3128_CR36","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/jvi.67.3.1365-1372.1993","volume":"67","author":"Y Gaudin","year":"1993","unstructured":"Gaudin Y, Ruigrok RW, Knossow M, Flamand A (1993) Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion. J Virol 67(3):1365\u20131372","journal-title":"J Virol"},{"issue":"37","key":"3128_CR37","doi-asserted-by":"publisher","first-page":"15414","DOI":"10.1073\/pnas.1110854108","volume":"108","author":"KT Beier","year":"2011","unstructured":"Beier KT, Saunders A, Oldenburg IA, Miyamichi K, Akhtar N, Luo L, Whelan SP, Sabatini B, Cepko CL (2011) Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors. Proc Natl Acad Sci USA 108(37):15414\u201315419","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7149","key":"3128_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nature05901","volume":"448","author":"P Kumar","year":"2007","unstructured":"Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, Lee SK, Shankar P, Manjunath N (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448(7149):39\u201343","journal-title":"Nature"},{"issue":"21","key":"3128_CR39","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1016\/j.biomaterials.2011.03.047","volume":"32","author":"DW Hwang","year":"2011","unstructured":"Hwang DW, Son S, Jang J, Youn H, Lee S, Lee D, Lee YS, Jeong JM, Kim WJ, Lee DS (2011) A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials 32(21):4968\u20134975","journal-title":"Biomaterials"},{"issue":"5","key":"3128_CR40","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/mt.2010.27","volume":"18","author":"SS Kim","year":"2010","unstructured":"Kim SS, Ye C, Kumar P, Chiu I, Subramanya S, Wu H, Shankar P, Manjunath N (2010) Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther 18(5):993\u20131001","journal-title":"Mol Ther"},{"issue":"25","key":"3128_CR41","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","volume":"30","author":"Y Liu","year":"2009","unstructured":"Liu Y, Huang R, Han L, Ke W, Shao K, Ye L, Lou J, Jiang C (2009) Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials 30(25):4195\u20134202","journal-title":"Biomaterials"},{"issue":"6","key":"3128_CR42","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1007\/s11095-012-0667-y","volume":"29","author":"A Fu","year":"2012","unstructured":"Fu A, Wang Y, Zhan L, Zhou R (2012) Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide. Pharm Res 29(6):1562\u20131569","journal-title":"Pharm Res"},{"issue":"8","key":"3128_CR43","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3109\/1061186X.2010.523788","volume":"19","author":"L Xiang","year":"2011","unstructured":"Xiang L, Zhou R, Fu A, Xu X, Huang Y, Hu C (2011) Targeted delivery of large fusion protein into hippocampal neurons by systemic administration. J Drug Target 19(8):632\u2013636","journal-title":"J Drug Target"},{"issue":"6","key":"3128_CR44","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1021\/mp100238j","volume":"7","author":"C Zhan","year":"2010","unstructured":"Zhan C, Yan Z, Xie C, Lu W (2010) Loop 2 of Ophiophagus hannah toxin b binds with neuronal nicotinic acetylcholine receptors and enhances intracranial drug delivery. Mol Pharm 7(6):1940\u20131947","journal-title":"Mol Pharm"},{"issue":"3","key":"3128_CR45","first-page":"221","volume":"2","author":"DL Donnelly-Roberts","year":"1989","unstructured":"Donnelly-Roberts DL, Lentz TL (1989) Synthetic peptides of neurotoxins and rabies virus glycoprotein behave as antagonists in a functional assay for the acetylcholine receptor. Pept Res 2(3):221\u2013226","journal-title":"Pept Res"},{"issue":"6","key":"3128_CR46","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1099\/0022-1317-83-6-1465","volume":"83","author":"AP Maillard","year":"2002","unstructured":"Maillard AP, Gaudin Y (2002) Rabies virus glycoprotein can fold in two alternative, antigenically distinct conformations depending on membrane-anchor type. J Gen Virol 83(6):1465\u20131476","journal-title":"J Gen Virol"},{"issue":"Pt7","key":"3128_CR47","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1099\/0022-1317-80-7-1647","volume":"80","author":"Y Gaudin","year":"1999","unstructured":"Gaudin Y, Moreira S, Benejean J, Blondel D, Flamand A, Tuffereau C (1999) Soluble ectodomain of rabies virus glycoprotein expressed in eukaryotic cells folds in a monomeric conformation that is antigenically distinct from the native state of the complete, membrane-anchored glycoprotein. J Gen Virol 80(Pt7):1647\u20131656","journal-title":"J Gen Virol"},{"issue":"15","key":"3128_CR48","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1016\/S0021-9258(19)50073-4","volume":"267","author":"SH Shakin-Eshleman","year":"1992","unstructured":"Shakin-Eshleman SH, Remaley AT, Eshleman JR, Wunner WH, Spitalnik SL (1992) N-linked glycosylation of rabies virus glycoprotein. Individual sequons differ in their glycosylation efficiencies and influence on cell surface expression. J Biol Chem 267(15):10690\u201310698","journal-title":"J Biol Chem"},{"issue":"1","key":"3128_CR49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JVI.73.1.242-250.1999","volume":"73","author":"T Mebatsion","year":"1999","unstructured":"Mebatsion T, Weiland F, Conzelmann KK (1999) Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol 73(1):242\u2013250","journal-title":"J Virol"},{"issue":"3\u20134","key":"3128_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.vetmic.2005.04.007","volume":"108","author":"PK Gupta","year":"2005","unstructured":"Gupta PK, Sharma S, Walunj SS, Chaturvedi VK, Raut AA, Patial S, Rai A, Pandey KD, Saini M (2005) Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus. Vet Microbiol 108(3\u20134):207\u2013214","journal-title":"Vet Microbiol"},{"issue":"2","key":"3128_CR51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12275-013-2337-0","volume":"51","author":"W Qian","year":"2013","unstructured":"Qian W, Aguilar F, Wang T, Qiu B (2013) Secretion of truncated recombinant rabies virus glycoprotein with preserved antigenic properties using a co-expression system in Hansenula polymorpha. J Microbiol 51(2):234\u2013240","journal-title":"J Microbiol"},{"issue":"2","key":"3128_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.virusres.2005.05.002","volume":"113","author":"A Rath","year":"2005","unstructured":"Rath A, Choudhury S, Batra D, Kapre SV, Rupprecht CE, Gupta SK (2005) DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response. Virus Res 113(2):143\u2013152","journal-title":"Virus Res"},{"issue":"2","key":"3128_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/prep.1996.0026","volume":"7","author":"BS Wojczyk","year":"1996","unstructured":"Wojczyk BS, Czerwinski M, Stwora-Wojczyk MM, Siegel DL, Abrams WR, Wunner WH, Spitalnik SL (1996) Purification of a secreted form of recombinant rabies virus glycoprotein: comparison of two affinity tags. Prot Exp Purif 7(2):183\u2013193","journal-title":"Prot Exp Purif"},{"issue":"2","key":"3128_CR54","first-page":"87","volume":"50","author":"PK Gupta","year":"2006","unstructured":"Gupta PK, Sharma S, Walunj SS, Patil AA, Rai A, Saini M (2006) A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection. Acta Virol 50(2):87\u201392","journal-title":"Acta Virol"},{"issue":"52","key":"3128_CR55","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.1016\/j.vaccine.2008.10.020","volume":"26","author":"S Niederh\u00e4user","year":"2008","unstructured":"Niederh\u00e4user S, Bruegger D, Zahno ML, Vogt HR, Peterhans E, Zanoni R, Bertoni G (2008) A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals. Vaccine 26(52):6749\u20136753","journal-title":"Vaccine"},{"issue":"10","key":"3128_CR56","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1128\/CVI.05258-11","volume":"18","author":"R Ramya","year":"2011","unstructured":"Ramya R, Mohana Subramanian B, Sivakumar V, Senthilkumar RL, Sambasiva Rao KR, Srinivasan VA (2011) Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice. Clin Vaccine Immunol 18(10):1673\u20131679","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"3128_CR57","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1128\/jvi.64.8.3804-3809.1990","volume":"64","author":"B Dietzschold","year":"1990","unstructured":"Dietzschold B, Gore M, Marchadier D, Niu HS, Bunschoten HM, Otvos L Jr, Wunner WH, Ertl HC, Osterhaus AD, Koprowski H (1990) Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J Virol 64(8):3804\u20133809","journal-title":"J Virol"},{"issue":"1","key":"3128_CR58","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/biot.200600211","volume":"2","author":"AY Yokomizo","year":"2007","unstructured":"Yokomizo AY, Jorge SAC, Astray RM, Fernandes I, Ribeiro OG, Horton DSPQ, Tonso A, Tordo N, Pereira CA (2007) Rabies virus glycoprotein expression in Drosophila S2 cells. I. Functional recombinant protein in stable co-transfected cell line. Biotechnol J 2(1):102\u2013109","journal-title":"Biotechnol J"},{"issue":"4","key":"3128_CR59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jbiotec.2008.12.009","volume":"139","author":"R Benmaamar","year":"2009","unstructured":"Benmaamar R, Astray RM, Wagner R, Pereira CA (2009) High-level expression of rabies virus glycoprotein with the RNA-based Semliki forest virus expression vector. J Biotechnol 139(4):283\u2013290","journal-title":"J Biotechnol"},{"issue":"2","key":"3128_CR60","doi-asserted-by":"publisher","first-page":"e87105","DOI":"10.1371\/journal.pone.0087105","volume":"9","author":"X Liu","year":"2014","unstructured":"Liu X, Yang Y, Sun Z, Chen J, Ai J, Dun C, Fu ZF, Niu X, Guo X (2014) A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge. PLoS One 9(2):e87105","journal-title":"PLoS One"},{"issue":"9","key":"3128_CR61","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1007\/s00705-015-2512-1","volume":"160","author":"S Wang","year":"2015","unstructured":"Wang S, Sun C, Zhang S, Zhang X, Liu Y, Wang Y, Zhang F, Wu X, Hu R (2015) Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant. Arch Virol 160(9):2315\u20132323","journal-title":"Arch Virol"},{"issue":"4","key":"3128_CR62","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1128\/JVI.01552-10","volume":"85","author":"Y Wen","year":"2011","unstructured":"Wen Y, Wang H, Wu H, Yang F, Tripp RA, Hogan RJ, Fu ZF (2011) Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. J Virol 85(4):1634\u20131644","journal-title":"J Virol"},{"issue":"2","key":"3128_CR63","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1099\/0022-1317-72-2-359","volume":"72","author":"SR Burger","year":"1991","unstructured":"Burger SR, Remaley AT, Danley JM, Moore J, Muschel RJ, Wunner WH, Spitalnik SL (1991) Stable expression of rabies virus glycoprotein in Chinese hamster ovary cells. J Gen Virol 72(2):359\u2013367","journal-title":"J Gen Virol"},{"issue":"11","key":"3128_CR64","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1348-0421.2004.tb03617.x","volume":"48","author":"M Sakai","year":"2004","unstructured":"Sakai M, Kankanamge PJ, Shoji J, Kawata S, Tochikura TS, Kawai A (2004) Studies on the conditions required for structural and functional maturation of rabies virus glycoprotein (G) in G cDNA-transfected cells. Microbiol Immunol 48(11):853\u2013864","journal-title":"Microbiol Immunol"},{"issue":"5838","key":"3128_CR65","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/294275a0","volume":"294","author":"A Anilionis","year":"1981","unstructured":"Anilionis A, Wunner WH, Curtis PJ (1981) Structure of the glycoprotein gene in rabies virus. Nature 294(5838):275\u2013278","journal-title":"Nature"},{"issue":"3\u20134","key":"3128_CR66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF01309439","volume":"128","author":"SR Klepfer","year":"1993","unstructured":"Klepfer SR, Debouck C, Uffelman J, Jacobs P, Bollen A, Jones EV (1993) Characterization of rabies glycoprotein expressed in yeast. Arch Virol 128(3\u20134):269\u2013286","journal-title":"Arch Virol"},{"issue":"5","key":"3128_CR67","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00253-010-2721-1","volume":"87","author":"K De Pourcq","year":"2010","unstructured":"De Pourcq K, De Schutter K, Callewaert N (2010) Engineering of glycosylation in yeast and other fungi: current state and perspectives. Appl Microbiol Biotechnol 87(5):1617\u20131631","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"3128_CR68","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0264-410X(98)00196-0","volume":"17","author":"S Sakamoto","year":"1999","unstructured":"Sakamoto S, Ide T, Tokiyoshi S, Nakao J, Hamada F, Yamamoto M, Grosby JA, Ni Y, Kawai A (1999) Studies on the structures and antigenic properties of rabies virus glycoprotein analogues produced in yeast cells. Vaccine 17(3):205\u2013218","journal-title":"Vaccine"},{"issue":"10","key":"3128_CR69","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1094\/PHYTO.2001.91.10.941","volume":"91","author":"N Fleysh","year":"2001","unstructured":"Fleysh N, Deka D, Drath M, Koprowski H, Yusibov V (2001) Pathogenesis of Alfalfa mosaic virus in soybean (Glycine max) and expression of chimeric rabies peptide in virus-infected soybean plants. Phytopathology 91(10):941\u2013947","journal-title":"Phytopathology"},{"issue":"37","key":"3128_CR70","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1016\/j.vaccine.2012.06.039","volume":"30","author":"E Loza-Rubio","year":"2012","unstructured":"Loza-Rubio E, Rojas-Anaya E, L\u00f3pez J, Olivera-Flores MT, G\u00f3mez-Lim M, Tapia-P\u00e9rez G (2012) Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies v\u00edrus glycoprotein. Vaccine 30(37):5551\u20135556","journal-title":"Vaccine"},{"issue":"2","key":"3128_CR71","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pep.2009.10.002","volume":"70","author":"S Roy","year":"2010","unstructured":"Roy S, Tyagi A, Tiwari S, Singh A, Sawant SV, Singh PK, Tuli R (2010) Rabies glycoprotein fused with B subunit of cholera toxin expressed in tobacco plants folds into biologically active pentameric protein. Protein Expr Purif 70(2):184\u2013190","journal-title":"Protein Expr Purif"},{"issue":"4","key":"3128_CR72","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12033-014-9829-y","volume":"57","author":"A Singh","year":"2015","unstructured":"Singh A, Srivastava S, Chouksey A, Panwar BS, Verma PC, Roy S, Singh PK, Saxena G, Tuli R (2015) Expression of rabies glycoprotein and ricin toxin B chain (RGP-RTB) fusion protein in tomato hairy roots: a step towards oral vaccination rabies. Mol Biotechnol 57(4):359\u2013370","journal-title":"Mol Biotechnol"},{"key":"3128_CR73","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/978-1-4939-3389-1_36","volume":"1404","author":"A Singh","year":"2016","unstructured":"Singh A, Saxena G, Verma PC (2016) Oral rabies vaccine design for expression in plants. Methods Mol Biol 1404:547\u2013567","journal-title":"Methods Mol Biol"},{"issue":"12","key":"3128_CR74","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00299-009-0782-3","volume":"28","author":"S Tiwari","year":"2009","unstructured":"Tiwari S, Mishra DK, Roy S, Singh A, Singh PK, Tuli R (2009) High level expression of a functionally active cholera toxin B: rabies glycoprotein fusion protein in tobacco seeds. Plant Cell Rep 28(12):1827\u20131836","journal-title":"Plant Cell Rep"},{"issue":"2","key":"3128_CR75","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/infdis\/jiu085","volume":"210","author":"CJ van Dolleweerd","year":"2014","unstructured":"van Dolleweerd CJ, The AY, Banyard AC, Both L, Lotter-Stark HC, Tsekoa T, Phahladira B, Shumba W, Chakauya E, Sabeta CT, Gruber C, Fooks AR, Chikwamba RK, Ma JK (2014) Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody. J Infect Dis 210(2):200\u2013208","journal-title":"J Infect Dis"},{"issue":"13","key":"3128_CR76","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/nbt1295-1484","volume":"13","author":"PB McGarvey","year":"1995","unstructured":"McGarvey PB, Hammond J, Dienelt MM, Hooper DC, Fu ZF, Dietzschold B, Koprowski H, Michaels FH (1995) Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology 13(13):1484\u20131487","journal-title":"Biotechnology"},{"issue":"1","key":"3128_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbiotec.2005.06.009","volume":"119","author":"S Ashraf","year":"2005","unstructured":"Ashraf S, Singh PK, Yadav DK, Shahnawaz M, Mishra S, Sawant SV, Tuli R (2005) High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice. J Biotechnol 119(1):1\u201314","journal-title":"J Biotechnol"},{"issue":"2","key":"3128_CR78","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0042-6822(89)90551-5","volume":"173","author":"C Prehaud","year":"1989","unstructured":"Prehaud C, Takehara K, Flamand A, Bishop DH (1989) Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors. Virology 173(2):390\u2013399","journal-title":"Virology"},{"issue":"3","key":"3128_CR79","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biotechadv.2011.10.009","volume":"30","author":"AM Moraes","year":"2012","unstructured":"Moraes AM, Jorge SA, Astray RM, Suazo CA, Calder\u00f3n Riquelme CE, Augusto EF, Tonso A, Pamboukian MM, Piccoli RA, Barral MF, Pereira CA (2012) Drosophila melanogaster S2 cells for expression of heterologous genes: From gene cloning to bioprocess development. Biotechnol Adv 30(3):613\u2013628","journal-title":"Biotechnol Adv"},{"issue":"1","key":"3128_CR80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10616-008-9130-7","volume":"57","author":"K Swiech","year":"2008","unstructured":"Swiech K, Rossi N, Silva BG, Jorge SAC, Astray RM, Suazo CAT (2008) Bioreactor culture of recombinant Drosophila melanogaster S2 cells: characterization of metabolic features related to cell growth and production of the rabies virus glycoprotein. Cytotechnology 57(1):61\u201366","journal-title":"Cytotechnology"},{"issue":"1","key":"3128_CR81","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10616-008-9139-y","volume":"57","author":"ALL Galesi","year":"2008","unstructured":"Galesi ALL, Aguiar MA, Astray RM, Augusto EFP, Moraes AM (2008) Growth of recombinant Drosophila melanogaster Schneider 2 cells producing rabies virus glycoprotein in bioreactor employing serum-free medium. Cytotechnology 57(1):73\u201381","journal-title":"Cytotechnology"},{"issue":"1","key":"3128_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10616-008-9141-4","volume":"57","author":"RZ Mendon\u00e7a","year":"2008","unstructured":"Mendon\u00e7a RZ, Greco KN, Sousa APB, Moraes RHP, Astray RM, Pereira CA (2008) Enhancing effect of a protein from Lonomia obliqua hemolymph on recombinant protein production. Cytotechnology 57(1):83\u201391","journal-title":"Cytotechnology"},{"issue":"2","key":"3128_CR83","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jbiotec.2009.07.003","volume":"143","author":"MA Lemos","year":"2009","unstructured":"Lemos MA, dos Santos AS, Astray RM, Pereira CA, Jorge SAC (2009) Rabies virus glycoprotein expression in Drosophila S2 cells. I: design of expression\/selection vectors, subpopulations selection and influence of sodium butyrate and culture medium on protein expression. J Biotechnol 143(2):103\u2013110","journal-title":"J Biotechnol"},{"issue":"3","key":"3128_CR84","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1385\/MB:28:3:241","volume":"28","author":"SA Brooks","year":"2004","unstructured":"Brooks SA (2004) Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system. Mol Biotechnol 28(3):241\u2013255","journal-title":"Mol Biotechnol"},{"issue":"3","key":"3128_CR85","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00253-005-1980-8","volume":"68","author":"M Butler","year":"2005","unstructured":"Butler M (2005) Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol 68(3):283\u2013291","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"3128_CR86","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1099\/0022-1317-73-2-335","volume":"73","author":"K Morimoto","year":"1992","unstructured":"Morimoto K, Kawai A, Mifune K (1992) Comparison of rabies virus G proteins produced by cDNA-transfected animal cells that display either inducible or constitutive expression of the gene. J Gen Virol 73(2):335\u2013345","journal-title":"J Gen Virol"},{"issue":"1","key":"3128_CR87","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/JVI.73.1.510-518.1999","volume":"73","author":"K Morimoto","year":"1999","unstructured":"Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B (1999) Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J Virol 73(1):510\u2013518","journal-title":"J Virol"},{"issue":"24","key":"3128_CR88","doi-asserted-by":"publisher","first-page":"14756","DOI":"10.1074\/jbc.270.24.14756","volume":"270","author":"L Kasturi","year":"1995","unstructured":"Kasturi L, Eshleman JR, Wunner WH, Shakin-Eshleman SH (1995) The hydroxy amino acid in an Asn-X-Ser\/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein. J Biol Chem 270(24):14756\u201314761","journal-title":"J Biol Chem"},{"issue":"6","key":"3128_CR89","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/glycob\/cwi046","volume":"15","author":"BS Wojczyk","year":"2005","unstructured":"Wojczyk BS, Takahashi N, Levy MT, Andrews DW, Abrams WR, Wunner WH, Spitalnik SL (2005) N-glycosylation at one rabies virus glycoprotein sequon influences N-glycan processing at a distant sequon on the same molecule. Glycobiology 15(6):655\u2013666","journal-title":"Glycobiology"},{"issue":"2","key":"3128_CR90","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/jvi.68.2.713-719.1994","volume":"68","author":"KK Conzelmann","year":"1994","unstructured":"Conzelmann KK, Schnell M (1994) Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins. J Virol 68(2):713\u2013719","journal-title":"J Virol"},{"issue":"18","key":"3128_CR91","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","volume":"13","author":"MJ Schnell","year":"1994","unstructured":"Schnell MJ, Mebatsion T, Conzelmann KK (1994) Infectious rabies viruses from cloned cDNA. EMBO J 13(18):4195\u20134203","journal-title":"EMBO J"},{"issue":"7","key":"3128_CR92","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3390\/v6072531","volume":"6","author":"CC Stobart","year":"2014","unstructured":"Stobart CC, Moore ML (2014) RNA virus reverse genetics and vaccine design. Viruses 6(7):2531\u20132550","journal-title":"Viruses"},{"issue":"4","key":"3128_CR93","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13365-015-0350-2","volume":"21","author":"S Zhu","year":"2015","unstructured":"Zhu S, Li H, Wang C, Luo F, Guo C (2015) Reverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development. J Neurovirol 21(4):335\u2013345","journal-title":"J Neurovirol"},{"key":"3128_CR94","first-page":"175","volume-title":"Laboratory Techniques in Rabies","author":"B Dietzschold","year":"1996","unstructured":"Dietzschold B (1996) Techniques for the purification of rabies virus, its subunits and recombinant products. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory Techniques in Rabies, 4th edn. WHO, Geneva, pp 175\u2013180","edition":"4"},{"issue":"3","key":"3128_CR95","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/iai.16.3.754-759.1977","volume":"16","author":"JH Cox","year":"1977","unstructured":"Cox JH, Dietzschold B, Schneider LG (1977) Rabies virus glycoprotein II. Biological and serological characterization. Infect Immun 16(3):754\u2013759","journal-title":"Infect Immun"},{"issue":"6","key":"3128_CR96","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10930-012-9420-y","volume":"31","author":"DK Yadav","year":"2012","unstructured":"Yadav DK, Ashraf S, Singh PK, Tuli R (2012) Localization of rabies virus glycoprotein into the endoplasmic reticulum produces immunoprotective antigen. Protein J 31(6):447\u2013456","journal-title":"Protein J"},{"issue":"1","key":"3128_CR97","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/biot.200700179","volume":"3","author":"RM Astray","year":"2008","unstructured":"Astray RM, Augusto E, Yokomizo AY, Pereira CA (2008) Analytical approach for the extraction of recombinant membrane viral glycoprotein from stably transfected Drosophila melanogaster cells. Biotechnol J 3(1):98\u2013103","journal-title":"Biotechnol J"},{"issue":"5","key":"3128_CR98","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/jcm.27.5.899-902.1989","volume":"27","author":"M Grassi","year":"1989","unstructured":"Grassi M (1989) Enzyme-linked immunosorbent assay for determination of antibodies to the envelope glycoprotein of rabies virus. J Clin Microbiol 27(5):899\u2013902","journal-title":"J Clin Microbiol"},{"issue":"3","key":"3128_CR99","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jsb.2007.07.001","volume":"160","author":"CR Midgett","year":"2007","unstructured":"Midgett CR, Madden DR (2007) Breaking the bottleneck: eukaryotic membrane protein expression for high-resolution structural studies. J Struct Biol 160(3):265\u2013274","journal-title":"J Struct Biol"},{"issue":"2","key":"3128_CR100","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10969-006-9011-2","volume":"7","author":"K Lundstro","year":"2006","unstructured":"Lundstro K, Wagner R, Reinhart C, Desmyter A, Cherouati N, Magnin T, Zeder-Lutz G, Courtot M, Prual C, Andr\u00e9 N, Hassaine G, Michel H, Cambillau C, Pattus F (2006) Structural genomics on membrane proteins: comparison of more than 100 GPCRs in 3 expression systems. J Struct Funct Genom 7(2):77\u201391","journal-title":"J Struct Funct Genom"},{"issue":"4","key":"3128_CR101","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jbiotec.2010.02.011","volume":"146","author":"DC Ventini","year":"2010","unstructured":"Ventini DC, Astray RM, Lemos MAN, Jorge SAC, Calderon C, Suazo CAT, Tonso A, Pereira CA (2010) Recombinant rabies virus glycoprotein synthesis in bioreactor by transfected Drosophila melanogaster S2 cells carrying a constitutive or an inducible promoter. J Biotechnol 146(4):169\u2013172","journal-title":"J Biotechnol"},{"issue":"5990","key":"3128_CR102","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/312163a0","volume":"312","author":"MP Kieny","year":"1984","unstructured":"Kieny MP, Lathe R, Drillien R, Spehner D, Skory S, Schmitt D, Wiktor T, Koprowski H, Lecocq JP (1984) Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312(5990):163\u2013166","journal-title":"Nature"},{"issue":"1","key":"3128_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","volume":"84","author":"BL Jacobs","year":"2009","unstructured":"Jacobs BL, Langland JO, Kibler KV, Denzler KL, White SD, Holechek SA, Wong S, Huynh T, Baskin CR (2009) Vaccinia virus vaccines: past, present and future. Antivir Res 84(1):1\u201313","journal-title":"Antivir Res"},{"issue":"3","key":"3128_CR104","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1017\/S0950268800052535","volume":"116","author":"PP Pastoret","year":"1996","unstructured":"Pastoret PP, Brochier B (1996) The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur. Epidemiol Infect 116(3):235\u2013240","journal-title":"Epidemiol Infect"},{"issue":"8","key":"3128_CR105","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.vaccine.2013.12.015","volume":"32","author":"LJ Brown","year":"2014","unstructured":"Brown LJ, Rosatte RC, Fehlner-Gardiner C, Bachmann P, Ellison JA, Jackson FR, Taylor JS, Davies C, Donovan D (2014) Oral vaccination and protection of red foxes (Vulpes vulpes) against rabies using ONRAB, an adenovirus-rabies recombinant vaccine. Vaccine 32(8):984\u2013989","journal-title":"Vaccine"},{"issue":"3","key":"3128_CR106","doi-asserted-by":"publisher","first-page":"582","DOI":"10.7589\/2013-08-207","volume":"50","author":"D Slate","year":"2014","unstructured":"Slate D, Chipman RB, Algeo TP, Mills SA, Nelson KM, Croson CK, Dubovi EJ, Vercauteren K, Renshaw RW, Atwood T, Johnson S, Rupprecht CE (2014) Safety and immunogenicity of Ontario Rabies Vaccine Bait (ONRAB) in the first US field trial in raccoons (Procyon lotor). J Wildl Dis 50(3):582\u2013595","journal-title":"J Wildl Dis"},{"key":"3128_CR107","first-page":"467","volume":"131","author":"N Tordo","year":"2008","unstructured":"Tordo N, Foumier A, Jallet C, Szelechowski M, Klonjkowski B, Eloit M (2008) Canine adenovirus based rabies vaccines. Dev Biol (Basel) 131:467\u2013476","journal-title":"Dev Biol (Basel)"},{"issue":"4","key":"3128_CR108","doi-asserted-by":"publisher","first-page":"752","DOI":"10.7589\/0090-3558-34.4.752","volume":"34","author":"DE Roscoe","year":"1998","unstructured":"Roscoe DE, Holste WC, Sorhage FE, Campbell C, Nlezgoda M, Buchannan R, Diehl D, Niu HS, Charles C (1998) Efficacy of an oral vaccinia-rabies glycoprotein recombinant vaccine in controlling epidemic raccoon rabies in New Jersey. J Wildl Dis 34(4):752\u2013763","journal-title":"J Wildl Dis"},{"issue":"4","key":"3128_CR109","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7589\/2012-01-023","volume":"48","author":"LJ Brown","year":"2012","unstructured":"Brown LJ, Rosatte RC, Fehlner-Gardiner C, Taylor JS, Davies JC, Donovan D (2012) Immune response and protection in raccoons (Procyon lotor) following consumption of baits containing ONRAB\u00ae, a human adenovirus rabies glycoprotein recombinant vaccine. J Wildl Dis 48(4):1010\u20131020","journal-title":"J Wildl Dis"},{"issue":"1","key":"3128_CR110","doi-asserted-by":"publisher","first-page":"157","DOI":"10.7589\/0090-3558-48.1.157","volume":"48","author":"C Fehlner-Gardiner","year":"2012","unstructured":"Fehlner-Gardiner C, Rudd R, Donovan D, Slate D, Kempf L, Badcock J (2012) Comparing ONRAB\u00ae and RABORAL V-RG\u00ae oral rabies vaccine field performance in raccoons and striped skunks, New Brunswick, Canada, and Maine, USA. J Wildl Dis 48(1):157\u2013167","journal-title":"J Wildl Dis"},{"issue":"1","key":"3128_CR111","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.antiviral.2013.07.012","volume":"100","author":"F Cliquet","year":"2013","unstructured":"Cliquet F, Robardet E, Picard Meyer E (2013) Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination. Antivir Res 100(1):84\u201389","journal-title":"Antivir Res"},{"key":"3128_CR112","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.antiviral.2015.06.011","volume":"121","author":"L Shuai","year":"2015","unstructured":"Shuai L, Feng N, Wang X, Ge J, Wen Z, Chen W, Qin L, Xia X, Bu Z (2015) Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination. Antivir Res 121:9\u201315","journal-title":"Antivir Res"},{"issue":"16","key":"3128_CR113","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1128\/JVI.00519-11","volume":"85","author":"J Ge","year":"2011","unstructured":"Ge J, Wang X, Tao L, Wen Z, Feng N, Yang S, Xia X, Yang C, Chen H, Bu Z (2011) Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. J Virol 85(16):8241\u20138252","journal-title":"J Virol"},{"issue":"9\u201310","key":"3128_CR114","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0264-410X(97)00285-5","volume":"16","author":"X Xuan","year":"1998","unstructured":"Xuan X, Tuchiya K, Sato I, Nishikawa Y, Onoderaz Y, Takashima Y, Yamamoto A, Katsumata A, Iwata A, Ueda S, Mikami T, Otsuka H (1998) Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector. Vaccine 16(9\u201310):969\u2013976","journal-title":"Vaccine"},{"issue":"12\u201313","key":"3128_CR115","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/S0264-410X(97)00062-5","volume":"15","author":"L Hu","year":"1997","unstructured":"Hu L, Ngichabe C, Trimarchi CV, Esposito JJ, Scott FW (1997) Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine. Vaccine 15(12\u201313):1466\u20131472","journal-title":"Vaccine"},{"issue":"51","key":"3128_CR116","doi-asserted-by":"publisher","first-page":"7198","DOI":"10.1016\/j.vaccine.2009.09.033","volume":"27","author":"J Weyer","year":"2009","unstructured":"Weyer J, Rupprecht CE, Nel LH (2009) Poxvirus-vectored vaccines for rabies\u2014a review. Vaccine 27(51):7198\u20137201","journal-title":"Vaccine"},{"issue":"21","key":"3128_CR117","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1016\/j.vaccine.2007.02.084","volume":"25","author":"J Weyer","year":"2007","unstructured":"Weyer J, Rupprecht CE, Mans J, Viljoen GJ, Nel LH (2007) Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Vaccine 25(21):4213\u20134222","journal-title":"Vaccine"},{"issue":"1\u20132","key":"3128_CR118","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.virol.2006.07.037","volume":"356","author":"J Li","year":"2006","unstructured":"Li J, Faber M, Papaneri A, Faber ML, McGettigan JP, Schnell MJ, Dietzschold B (2006) A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Virology 356(1\u20132):147\u2013154","journal-title":"Virology"},{"issue":"34","key":"3128_CR119","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1016\/j.vaccine.2012.06.001","volume":"30","author":"X Wang","year":"2012","unstructured":"Wang X, Feng N, Ge J, Shuai L, Peng L, Gao Y, Yang S, Xia X, Bu Z (2012) Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper. Vaccine 30(34):5067\u20135072","journal-title":"Vaccine"},{"issue":"6","key":"3128_CR120","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1128\/JVI.02886-12","volume":"87","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhou M, Gao X, Zhang G, Ren G, Gnanadurai CW, Fu ZF, He B (2013) A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein. J Virol 87(6):2986\u20132993","journal-title":"J Virol"},{"issue":"7","key":"3128_CR121","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1086\/382088","volume":"189","author":"PF Wright","year":"2004","unstructured":"Wright PF, Mestecky J, McElrath MJ, Keefer MC, Gorse GJ, Goepfert PA, Moldoveanu Z, Schwartz D, Spearman PW, El Habib R, Spring MD, Zhu Y, Smith C, Flores J, Weinhold KJ (2004) Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. J Infect Dis 189(7):1221\u20131231","journal-title":"J Infect Dis"},{"issue":"9","key":"3128_CR122","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/0264-410X(93)90379-C","volume":"11","author":"ZF Fu","year":"1993","unstructured":"Fu ZF, Rupprecht CE, Dietzschold B, Saikumar P, Niu HS, Babka I, Wunner WH, Koprowski H (1993) Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein. Vaccine 11(9):925\u2013928","journal-title":"Vaccine"},{"issue":"7","key":"3128_CR123","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","volume":"76","author":"M Faber","year":"2002","unstructured":"Faber M, Pulmanausahakul R, Hodawadekar SS, Spitsin S, McGettigan JP, Schnell MJ, Dietzschold B (2002) Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J Virol 76(7):3374\u20133381","journal-title":"J Virol"},{"key":"3128_CR124","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/1743-422X-8-454","volume":"8","author":"L Tao","year":"2011","unstructured":"Tao L, Ge J, Wang X, Wen Z, Zhai H, Hua T, Zhao B, Kong D, Yang C, Bu Z (2011) Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production. Virol J 8:454","journal-title":"Virol J"},{"issue":"3","key":"3128_CR125","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1128\/JVI.02470-12","volume":"87","author":"R Amann","year":"2013","unstructured":"Amann R, Rohde J, Wulle U, Conlee D, Raue R, Martinon O, Rziha HJ (2013) A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein. J Virol 87(3):1618\u20131630","journal-title":"J Virol"},{"issue":"50","key":"3128_CR126","doi-asserted-by":"publisher","first-page":"6405","DOI":"10.1016\/j.vaccine.2008.08.069","volume":"26","author":"J Cenna","year":"2008","unstructured":"Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, McGettigan JP (2008) Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Vaccine 26(50):6405\u20136414","journal-title":"Vaccine"},{"issue":"24","key":"3128_CR127","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1016\/j.vaccine.2014.02.029","volume":"32","author":"RM Astray","year":"2014","unstructured":"Astray RM, Ventini DC, Boldorini VLL, Silva FG, Rocca MP, Pereira CA (2014) Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors. Vaccine 32(24):2829\u20132832","journal-title":"Vaccine"},{"issue":"6","key":"3128_CR128","doi-asserted-by":"publisher","first-page":"e0004746","DOI":"10.1371\/journal.pntd.0004746","volume":"10","author":"M Schnee","year":"2016","unstructured":"Schnee M, Vogel AB, Voss D, Petsch B, Baumhof P, Kramps T, Stitz L (2016) An mRNA vaccine encoding rabies virus glycoprotein induces protection against lethal infection in mice and correlates of protection in adult and newborn pigs. PLoS Negl Trop Dis 10(6):e0004746","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-3128-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-016-3128-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-3128-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:56:28Z","timestamp":1744174588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-016-3128-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3128"],"URL":"https:\/\/doi.org\/10.1007\/s00705-016-3128-9","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]},"assertion":[{"value":"8 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was financially supported by grants to Renato Astray (FAPESP - 2012\/24647-0) and Carlos A Pereira (CNPq - 402439\/2013-9). C.A. Pereira is recipient of a CNPq 1A senior fellowship.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors (Renato M. Astray, Soraia A. C. Jorge and Carlos A. Pereira) declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}